Sentinel node biopsy using contrast-enhanced ultrasonography with Sonazoid in breast cancer

Sentinel node biopsy using contrast-enhanced ultrasonography with Sonazoid in breast cancer - Sentinel node biopsy using Sonazoid in breast cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000015366

Enrollment

100

Registered

2014-10-31

Start date

2014-08-02

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

primary breast cancer

Interventions

Sonazoid

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: T1-3N0M0 primary breast cancer PS0-1 age 20-80 patients who are not given informed consent

Exclusion criteria

Exclusion criteria: during pregnancy allergic to egg patients who are thought to be not suitable to this study

Design outcomes

Primary

Measure	Time frame
identification rate of sentinel node between conventional method and ultrasonography using sonazoid	—

Countries

Japan

Contacts

Public ContactKenzo Shimazu

Osaka University, Graduate School of Medicine Breast and Endocrine Surgery

kshimazu@onsurg.med.osaka-u.ac.jp06-6879-3772

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026